Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

MDA Staff

Featured Article

2021 Reader Photo Contest Winners

By MDA Staff | November 18, 2021
Blog Post

Improving Air Travel for People Living with a Disability

By MDA Staff | September 27, 2021
Blog Post

Clinical Trial Alert: Phase 3 Study of High Dose Eteplirsen in Boys with DMD

By MDA Staff | September 20, 2021
Blog Post

Clinical Trial Alert: Phase 2 Study of Ataluren in Children with Nonsense Mutation DMD

By MDA Staff | September 20, 2021
Featured Article

Researchers Want to Know More About Oculopharyngeal Muscular Dystrophy

By MDA Staff | August 20, 2021
Featured Article

One Bike Four Stories

By MDA Staff | August 20, 2021
Featured Article

Education Within Reach

By MDA Staff | August 20, 2021
Blog Post

Clinical Trial Alert: Phase 2 Study of Ifetroban in Individuals with DMD

By MDA Staff | August 18, 2021
Blog Post

Clinical Trial Alert: Phase 2/3 and Open-Label Extension Study of ASP0367 in Individuals with Primary Mitochondrial Myopathy

By MDA Staff | August 9, 2021
Blog Post

FDA Approves Sanofi Genzyme’s Nexviazyme for Treatment of Pompe Disease

By MDA Staff | August 6, 2021
  • « Previous
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 25
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1016 W Jackson Blvd #1073
Chicago, IL 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset